162 related articles for article (PubMed ID: 20616726)
21. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J
Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801
[TBL] [Abstract][Full Text] [Related]
22. Exploiting tolerance processes in transplantation.
Waldmann H; Cobbold S
Science; 2004 Jul; 305(5681):209-12. PubMed ID: 15247471
[TBL] [Abstract][Full Text] [Related]
23. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients.
Martínez-Llordella M; Lozano JJ; Puig-Pey I; Orlando G; Tisone G; Lerut J; Benítez C; Pons JA; Parrilla P; Ramírez P; Bruguera M; Rimola A; Sánchez-Fueyo A
J Clin Invest; 2008 Aug; 118(8):2845-57. PubMed ID: 18654667
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of immune monitoring in solid organ transplantation.
Daniel V; Opelz G
Int Rev Immunol; 2009; 28(3-4):155-84. PubMed ID: 19811320
[TBL] [Abstract][Full Text] [Related]
25. Identification of tolerant recipients following liver transplantation.
Sánchez-Fueyo A
Int Immunopharmacol; 2010 Dec; 10(12):1501-4. PubMed ID: 20601182
[TBL] [Abstract][Full Text] [Related]
26. Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients.
Brouard S; Le Bars A; Dufay A; Gosselin M; Foucher Y; Guillet M; Cesbron-Gautier A; Thervet E; Legendre C; Dugast E; Pallier A; Guillot-Gueguen C; Lagoutte L; Evanno G; Giral M; Soulillou JP
Transpl Int; 2011 Jun; 24(6):536-47. PubMed ID: 21457359
[TBL] [Abstract][Full Text] [Related]
27. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.
Louis S; Braudeau C; Giral M; Dupont A; Moizant F; Robillard N; Moreau A; Soulillou JP; Brouard S
Transplantation; 2006 Feb; 81(3):398-407. PubMed ID: 16477227
[TBL] [Abstract][Full Text] [Related]
28. A composite score associated with spontaneous operational tolerance in kidney transplant recipients.
Danger R; Chesneau M; Paul C; Guérif P; Durand M; Newell KA; Kanaparthi S; Turka LA; Soulillou JP; Houlgatte R; Giral M; Ramstein G; Brouard S
Kidney Int; 2017 Jun; 91(6):1473-1481. PubMed ID: 28242033
[TBL] [Abstract][Full Text] [Related]
29. Tolerance in Solid-Organ Transplant.
Fine RN
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):1-5. PubMed ID: 27805501
[TBL] [Abstract][Full Text] [Related]
30. Transplantation: tolerance.
Hutchings A; Thomas JM
Curr Opin Investig Drugs; 2003 May; 4(5):530-5. PubMed ID: 12833645
[TBL] [Abstract][Full Text] [Related]
31. Liver microRNA Profile of Induced Allograft Tolerance.
Vitalone MJ; Wei L; Fujiki M; Lau AH; Littau E; Esquivel C; Martinez OM; Krams SM
Transplantation; 2016 Apr; 100(4):781-90. PubMed ID: 26950716
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers in renal transplantation.
Bestard O; Cruzado JM; la Franquesa M; Grinyó JM
Curr Opin Organ Transplant; 2010 Aug; 15(4):467-73. PubMed ID: 20613522
[TBL] [Abstract][Full Text] [Related]
33. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
34. Induction therapy: why, when, and which agent?
Krischock L; Marks SD
Pediatr Transplant; 2010 May; 14(3):298-313. PubMed ID: 20345609
[TBL] [Abstract][Full Text] [Related]
35. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Charlton M; Seaberg E
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
[TBL] [Abstract][Full Text] [Related]
36. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
Pons JA; Revilla-Nuin B; Baroja-Mazo A; Ramírez P; Martínez-Alarcón L; Sánchez-Bueno F; Robles R; Rios A; Aparicio P; Parrilla P
Transplantation; 2008 Nov; 86(10):1370-8. PubMed ID: 19034005
[TBL] [Abstract][Full Text] [Related]
37. Rejection and acceptance of corneal allografts.
Klebe S; Coster DJ; Williams KA
Curr Opin Organ Transplant; 2009 Feb; 14(1):4-9. PubMed ID: 19337139
[TBL] [Abstract][Full Text] [Related]
38. Revisiting the effects of CMV on long-term transplant outcome.
Baron C; Forconi C; Lebranchu Y
Curr Opin Organ Transplant; 2010 Aug; 15(4):492-8. PubMed ID: 20631617
[TBL] [Abstract][Full Text] [Related]
39. Transplantation tolerance: gene expression profiles comparing allotolerance vs. allorejection.
Metcalfe SM; De S Muthukumarana PA
Int Immunopharmacol; 2005 Jan; 5(1):33-9. PubMed ID: 15589457
[TBL] [Abstract][Full Text] [Related]
40. Tolerance assays: measuring the unknown.
Newell KA; Larsen CP
Transplantation; 2006 Jun; 81(11):1503-9. PubMed ID: 16770237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
